Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Revenue (2019 - 2025)

Historic Revenue for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $272.3 million.

  • Legend Biotech's Revenue rose 6998.85% to $272.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $187.2 billion, marking a year-over-year increase of 13433.46%. This contributed to the annual value of $627.2 million for FY2024, which is 11997.42% up from last year.
  • Latest data reveals that Legend Biotech reported Revenue of $272.3 million as of Q3 2025, which was up 6998.85% from $255.1 million recorded in Q2 2025.
  • Legend Biotech's Revenue's 5-year high stood at $186.5 billion during Q4 2024, with a 5-year trough of $12.0 million in Q2 2022.
  • Over the past 5 years, Legend Biotech's median Revenue value was $73.3 million (recorded in 2023), while the average stood at $14.1 billion.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 4083.43% in 2022, then skyrocketed by 28746921.07% in 2023.
  • Legend Biotech's Revenue (Quarter) stood at $39.0 million in 2021, then fell by 29.14% to $27.6 million in 2022, then surged by 287469.21% to $79.5 billion in 2023, then soared by 134.73% to $186.5 billion in 2024, then crashed by 99.85% to $272.3 million in 2025.
  • Its Revenue stands at $272.3 million for Q3 2025, versus $255.1 million for Q2 2025 and $195.1 million for Q1 2025.